
Dyronib 50 mg Tablet is an oral anti-cancer medication containing Dasatinib, a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |




As a reliable supplier of generic anticancer medications, we provide Dyronib (Dasatinib 50 mg) Tablets, widely used for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
We ensure consistent, safe, and timely bulk supply of oncology drugs, including Dasatinib (Generic Sprycel), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.